Fudan University’s Furong Investment has co-led a round for Singlera Genomics, which will use the cash to advance its pipeline of cancer screening products.

Singlera Genomics, a China-based medical diagnostics technology developer, secured $150m in series B financing yesterday co-led by Furong Investment, a fund backed by Fudan University’s Ningbo Research Institute.
Investment bank China International Capital Corporation’s CICC Kai Tak Innovative Biomedicine Fund and private equity fund Detong Capital co-led the round.
Huamei International, Linden Asset Group, Wuxi Capital, FutureX Skyline Capital, Shanghai Free Trade Zone Fund and existing investors including Green Pine Capital Partners, Prosperico Ventures and Proxima Ventures filled…